In this regard, it is notable that pathogenic variants in DNM2 are well known to cause peripheral neuropathy [252,253,254,255,256], as well as centronuclear myopathy (CNM), characterized by weakness and slow progressive muscle loss [253,257,258,259]. This evidence concerns the gene DNM2 and peripheral neuropathy.